Distribution of Cytochrome P450 Metabolizer Status and Allelic Variants in Individuals with Mental Health Disorders in Ontario, Canada: Répartition du statut métabolique du cytochrome P450 et des variantes alléliques chez les personnes atteintes de problèmes de santé mentale en Ontario, au Canada
The Canadian Journal of Psychiatry · 2026-09 · 71 (9) · 703-711
DOI: 10.1177/07067437261451952 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Canadian Journal of Psychiatry, online erschienen am 04.06.2026. Verfasst von Megana Thamilselvan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and…. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Mental Disorders, Psychotropic Drugs. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Brain and Behavior Research Foundation, Canadian Institutes of Health Research, Tannenbaum Family Foundation.
Abstract (Originalsprache)
Introduction
Drug metabolism is primarily carried out by the cytochrome P450 (CYP) family of enzymes in the liver. Based on an individual's diplotype, they can be classified into poor (PM), intermediate (IM), normal (NM), rapid (RM) or ultrarapid (UM) metabolizers. Here, we show the distribution of allele frequency and metabolizer status across ancestries for CYP2D6, CYP2C19, CYP2C9, CYP2B6, CYP3A4 and CYP1A2 in a cohort from Ontario, Canada.
Methods
Patients currently taking or starting a psychotropic drug ( N = 8,280) were enrolled. Patients self-reported their ancestry, and DNA was analysed for the CYP2D6, CYP2C19, CYP2C9, CYP2B6, CYP3A4 and CYP1A2 genes using a commercial pharmacogenetic test and metabolizer status was assigned using ClinPGx as a reference.
Results
The cohort was primarily of European ancestry (70%), followed by individuals with mixed ancestry (9.3%). The combined frequency of PMs and UMs, representing the extremes of enzyme activity, was highest for CYP2C19 and CYP2D6, with this frequency being approximately 8% for each enzyme. The frequency varied considerably by ancestry, with up to 24% of individuals of Caribbean descent being CYP2C19 PMs or UMs, for example, compared to only 7% among those of Latin, Central and South American ancestry. Of the entire sample, only 5.1% were NMs across all enzymes, meaning 94.9% of individuals had a non-NM status and would benefit from pharmacogenetic testing.
Conclusion
Overall, this study provides a useful reference for variations in the CYP family of genes in the population of Ontario, Canada.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- Temerty Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
- Ontario Shores Center for Mental Health Sciences, Whitby, Ontario, Canada.
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- Division of Neurosciences and Clinical Translation, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Megana Thamilselvan, Alex J Coulter, Anashe Shahmirian, Daniel J Müller, Arun Kumar Tiwari, Clement C Zai, James L Kennedy
Förderung
- Brain and Behavior Research Foundation
- Canadian Institutes of Health Research
- Tannenbaum Family Foundation
- Ontario Ministry of Research and Innovation
- McLaughlin Foundation Grant.
Zitieren
APA
Thamilselvan, M., Coulter, A. J., Herbert, D., Shahmirian, A., King, N., Müller, D. J., Tiwari, A. K., Zai, C. C., & Kennedy, J. L. (2026). Distribution of Cytochrome P450 Metabolizer Status and Allelic Variants in Individuals with Mental Health Disorders in Ontario, Canada: Répartition du statut métabolique du cytochrome P450 et des variantes alléliques chez les personnes atteintes de problèmes de santé mentale en Ontario, au Canada. The Canadian Journal of Psychiatry, 71(9), 703-711. https://doi.org/10.1177/07067437261451952
Vancouver
Thamilselvan M, Coulter AJ, Herbert D, Shahmirian A, King N, Müller DJ, et al. Distribution of Cytochrome P450 Metabolizer Status and Allelic Variants in Individuals with Mental Health Disorders in Ontario, Canada: Répartition du statut métabolique du cytochrome P450 et des variantes alléliques chez les personnes atteintes de problèmes de santé mentale en Ontario, au Canada. The Canadian Journal of Psychiatry. 2026;71(9):703-711. doi:10.1177/07067437261451952
BibTeX
@article{Thamilselvan2026,
author = {Thamilselvan, Megana and Coulter, Alex J and Herbert, Deanna and Shahmirian, Anashe and King, Nicole and Müller, Daniel J and Tiwari, Arun Kumar and Zai, Clement C and Kennedy, James L},
title = {Distribution of Cytochrome P450 Metabolizer Status and Allelic Variants in Individuals with Mental Health Disorders in Ontario, Canada: Répartition du statut métabolique du cytochrome P450 et des variantes alléliques chez les personnes atteintes de problèmes de santé mentale en Ontario, au Canada},
journal = {The Canadian Journal of Psychiatry},
year = {2026},
volume = {71},
number = {9},
pages = {703--711},
doi = {10.1177/07067437261451952}
}
EUVIMED